Medicare Enrolled
Dr. Rommie Fakhoury, MD
Family Medicine · Rancho Cucamonga, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fakhoury from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fakhoury?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fakhoury
Dr. Rommie Fakhoury is a family medicine specialist in Rancho Cucamonga, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fakhoury performed 6,976 Medicare services across 1,295 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fakhoury received a total of $6,827 from 46 pharmaceutical and/or device companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fakhoury is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in CA
$6,827 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,976
Medicare services
Top 2% in CA for family medicine
1,295
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~367 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
1,343 | $32 | $100 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,009 | $41 | $93 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
962 | $39 | $79 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
732 | $83 | $154 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
669 | $38 | $110 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
466 | $49 | $65 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
448 | $122 | $204 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
321 | $11 | $26 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
254 | $0 | $26 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
253 | $0 | $5 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
129 | $8 | $13 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $59 | $103 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
119 | $1 | $13 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
36 | $133 | $254 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
30 | $36 | $64 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
30 | $24 | $87 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
18 | $15 | $38 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
17 | $17 | $40 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
14 | $11 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,827
Total received (2018-2024)
Avg $975/year across 7 years
Top 6% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
378
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,805 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,974
2023
$1,574
2022
$950
2021
$649
2020
$358
2019
$871
2018
$451
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$437
AstraZeneca Pharmaceuticals LP
$204
Antares Pharma, Inc.
$192
ABBVIE INC.
$188
Novo Nordisk Inc
$179
Lilly USA, LLC
$176
Almatica Pharma LLC
$134
GlaxoSmithKline, LLC.
$70
IBSA Pharma Inc.
$53
Phathom Pharmaceuticals, Inc.
$46
Amgen Inc.
$42
Verity Pharmaceuticals Inc.
$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$38
Kowa Pharmaceuticals America, Inc.
$37
Acella Pharmaceuticals, LLC
$30
Astellas Pharma US Inc
$25
Nevro Corp.
$24
PFIZER INC.
$22
Janssen Pharmaceuticals, Inc
$19
Exact Sciences Corporation
$18
Top 3 companies account for 42.2% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$913
Merz North America, Inc.
$668
Novo Nordisk Inc
$630
ABBVIE INC.
$464
PFIZER INC.
$407
Lilly USA, LLC
$371
AstraZeneca Pharmaceuticals LP
$358
Antares Pharma, Inc.
$284
AbbVie Inc.
$262
Horizon Therapeutics plc
$258
AbbVie, Inc.
$255
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$224
Almatica Pharma LLC
$209
GlaxoSmithKline, LLC.
$184
IBSA Pharma Inc.
$161
Amgen Inc.
$129
Takeda Pharmaceuticals U.S.A., Inc.
$106
Allergan Inc.
$87
Janssen Pharmaceuticals, Inc
$85
MERZ NORTH AMERICA, INC.
$70
Acerus Pharmaceuticals Corporation
$63
Allergan, Inc.
$59
Acella Pharmaceuticals, LLC
$46
Phathom Pharmaceuticals, Inc.
$46
Verity Pharmaceuticals Inc.
$40
Kowa Pharmaceuticals America, Inc.
$37
Exact Sciences Corporation
$36
Merck Sharp & Dohme Corporation
$32
Tolmar, Inc.
$28
Electronic Waveform Lab, Inc.
$27
Zyla Life Sciences, Inc.
$25
Biohaven Pharmaceutical Holding Company Ltd.
$25
Astellas Pharma US Inc
$25
Nevro Corp.
$24
Oxford Immunotec USA Inc
$24
AMAG Pharmaceuticals, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$20
Supernus Pharmaceuticals, Inc.
$18
Bayer Healthcare Pharmaceuticals Inc.
$18
Dexcom, Inc.
$17
RedHill Biopharma Inc.
$15
Otsuka America Pharmaceutical, Inc.
$14
Lupin Inc.
$12
SANOFI-AVENTIS U.S. LLC
$12
Zyla Life Sciences
$11
Apyx Medical Corporation
$7
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · Aimovig · Androgel · BEXSERO · BOTOX COSMETIC · BREZTRI · BYSTOLIC · CHANTIX · COMIRNATY · Cologuard Collection Kit · Creon · DUEXIS · Dexcom G6 Transmitter · Dexilant · EMGALITY · EUCRISA · FARXIGA · FLECTOR PATCH · FREESTYLE LIBRE 3 · GRALISE · INTRAROSA · JANUVIA · JATENZO · Kerendia · LINZESS · LO LOESTRIN FE · LOKELMA · LOREEV XR · LYRICA · MOUNJARO · NP Thyroid 60 · NUEDEXTA · NURTEC ODT · Natesto · OTREXUP · Otezla · Otrexup · Ozempic · PENNSAID · ProAir Digihaler · QULIPTA · RAYOS · Rybelsus · SEGLUROMET · SHINGRIX · SOLIQUA 100/33 · SOLOSEC · SPRIX · SYNTHROID · Senza · Synthroid · T-SPOT.TB8 · TERIPARATIDE · TRELEGY ELLIPTA · Talicia · Tirosint · Tlando · UBRELVY · Uloric · VOQUEZNA · VRAYLAR · Veozah · Wegovy · XARELTO · XEOMIN · XIFAXAN · XYOSTED · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
1,728
Per 100K population
79.0
County median income
$82,184
Nearest hospital
SAN ANTONIO REGIONAL HOSPITAL
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fakhoury is a clinical cardiology specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 6% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fakhoury experienced with remote vital sign monitoring management, each additional 20 minutes?
Based on Medicare claims data, Dr. Fakhoury performed 1,343 remote vital sign monitoring management, each additional 20 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fakhoury receive payments from pharmaceutical companies?
Yes. Dr. Fakhoury received a total of $6,827 from 46 companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fakhoury's costs compare to other family medicine physicians in Rancho Cucamonga?
Dr. Fakhoury's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fakhoury) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Rancho Cucamonga
Browse family medicine physicians in Rancho Cucamonga ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Merz North America, Inc. Payments to Doctors
See all physicians who received payments from Merz North America, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology